Newsmakers

Under the new entitlement agreement, Hoth Therapeutics secures annual NVIDIA AI Enterprise Essentials licenses to support its GPU-powered infrastructure, enabling advanced machine learning and neural network modeling capabilities for pharmaceutical research NEW YORK, Oct. 8, 2025  […]

Presentation to highlight advancements in Hoth’s clinical pipeline, including HT-001 for cancer-therapy-induced rash and HT-KIT, a novel oncology program targeting KIT-driven tumors NEW YORK, Oct. 7, 2025  — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company […]

Winnipeg, Manitoba–October 2, 2025 – Snow Lake Resources Ltd., d/b/a Snow Lake Energy (NASDAQ: LITM) (“Snow Lake“), a uranium exploration and development company, announces that an additional 15 drill holes have been completed on the […]

Winnipeg, Manitoba– October 6, 2025 – Snow Lake Resources Ltd., d/b/a Snow Lake Energy (NASDAQ: LITM) (Snow Lake), a uranium exploration and development company, is pleased to announce that it has entered into a definitive […]

Federal Collaboration Marks Major Milestone as Worksport Targets Multi-Billion-Dollar Heat Pump Market West Seneca, New York–October 6, 2025 – Worksport Ltd. (NASDAQ: WKSP) (“Worksport” or the “Company”), through its subsidiary Terravis Energy, today announced a […]

TAMPA, FL  / September 30, 2025 / Wellgistics Health, Inc. (“Wellgistics Health” or the “Company”) (NASDAQ:WGRX), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced a strategic collaboration with TheracosBio, […]

B2B Revenue Grows at 25% Monthly Geometric Rate; Dealer Adoption Accelerates Ahead of HD3 and Clean-Tech Launches West Seneca, New York, Sept. 30, 2025  — Worksport Ltd. (NASDAQ: WKSP) (“Worksport” or the “Company”), a U.S.-based […]

LIVERMORE, Calif., Sept. 29, 2025  — (NASDAQ: ADN) Advent Technologies Holdings, Inc., through its wholly owned subsidiary, Advent Technologies, SA, is pleased to announce a new contract with Siqens GmbH, a leading German fuel cell […]

MENIN inhibitors are a promising class of targeted oncology drugs in development for acute leukemias and certain solid tumors, but their use is often limited by severe dermatological side effects. HT-001 aims to address these […]

Q3 revenue on record pace; SOLIS & COR to launch late Q4; Terravis pursuing validation and global partnerships West Seneca, New York, Sept. 23, 2025 — Worksport Ltd. (NASDAQ: WKSP) (“Worksport” or the “Company”), a […]

In partnership with RxERP Financial, the program offers up to $350,000 per pharmacy and $1 million per wholesaler or manufacturer through trusted third-party financing partners, strengthening cash flow and supply chain resilience. TAMPA, FL / September […]

LIVERMORE, Calif., Sept. 22, 2025 — Advent Technologies Holdings, Inc. (NASDAQ: ADN), an innovation-driven leader in fuel cells and hydrogen technologies, has delivered its next generation, state-of-the-art Honey Badger 50™ (“HB50”) portable power units to […]

LIVERMORE, Calif., Sept. 09, 2025 — Advent Technologies Holdings, Inc. (NASDAQ: ADN) an innovation-driven leader in the fuel cell and hydrogen technology sector, is proud to announce a major technological breakthrough in its strategic collaboration […]

NEW YORK, Sept. 10, 2025 — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical innovator, today announced it has submitted its Clinical Trial Application (CTA) to the European Medicines Agency (EMA) to expand its ongoing Phase II trial of […]

Company Achieves Consistent Growth With Four Straight Record Months; Gross Margin Expands 2,000+ Basis Points in Three Quarters; Production Hits Strongest Levels to Date West Seneca, New York, Sept. 09, 2025 — Worksport Ltd. (NASDAQ: […]